Valproic acid-induced encephalopathy in very long course treated patients

Brain Injury

Volumn 23, Issue 12, 2009, Pages 981-984

  Rousseau, Marie Christine ^a   Montana, Marc ^a   Villano, Philippe ^a   Catala, Anne ^a   Blaya, José ^a   Valkov, Maria ^a   Allouard, Yves ^a   Bugni, Estelle ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Biomnis   (France)

Author keywords

Encephalopathy; Hyperammonaemia; Valproic acid

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AMMONIA; ANTICONVULSIVE AGENT; BACLOFEN; BILIRUBIN; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; ETIRACETAM; LACTULOSE; LAMOTRIGINE; LIVER ENZYME; OMEPRAZOLE; PHENOBARBITAL; PHENYTOIN; PROTEIN; TOPIRAMATE; TRIMEBUTINE; VALPROIC ACID;

ABSENCE; ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CEREBRAL PALSY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MONITORING; FEMALE; HUMAN; HYPERAMMONEMIA; INFANTILE SPASM; MAJOR CLINICAL STUDY; MALE; MENTAL DEFICIENCY; MONOTHERAPY; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; TONIC CLONIC SEIZURE; TREATMENT DURATION;

EID: 70449086407     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699050903302344     Document Type: Article

References (26)

1. Pinkston R, Walker LA. Multiorgan system failure caused by valproic acid toxicity. American Journal of Emergency Medicine 1997;15:504-506.
2. Verrotti A, Greco R, Morgese F, Chiarelli F. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. International Journal of Clinical and Laboratory Research 1999;29:36-40.
3. Murphy JV, Marquardt K. Asymptomatic hyperammonemia in patients receiving valproic acid. Archives of Neurology 1982;39:591-592.
4. Raja M, Azzoni A. Valproate-induced hyperammonemia. Journal of Clinical Psychopharmacology 2002;22:631-633.
5. Chicharro AV, de Marinis AJ, Kanner AM. The measurement of ammonemia blood levels in patients taking valproic acid: Looking for problems where they do not exist? Epilepsy and Behaviour 2007;11:361-366.
6. Mallet L, Babin S, Morais J. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman. The Annals of Pharmacotherapy 2004;38:1643-1647.
7. Batshaw ML, Brusilow SW. Valproate-induced hyperammonemia. Annals of Neurology 1982;11:319-321.
8. Williams CA, Tiefenbach S, McReynolds JW. Valproic acidinduced hyperammonemia in mentally retarded adults. Neurology 1984;34:550-553.
9. Gomceli YB, Kutl G, Cavdar L, Sanivar F, Inan L. Different clinical manifestations of hyperammonemic encephalopathy. Epilepsy and Behaviour 2007;10:583-587.
10. Wyllie E, Wyllie R, Rothner AD, Erenberg G, Cruse R. Valproate-induced hyperammonemia in asymptomatic children. Cleveland Clinic Quarterly 1983;50:275-277.
11. Altunbasak S, Baytok V, Tasouji M, Herguner O, Burgut R, Kayrin L. Asymptomatic hyperammonemia in children treated with valproic acid. Journal of Child Neurology 1997;12:461-463. (Pubitemid 28023537)
12. Gago MC, Novo I, Segade SR. Effects of valproic acid on the urea cycle and carnitine metabolism. International Pediatrics 1990;5:54-57.
13. Thom H, Carter PE, Cole GF. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs. Developmental Medicine and Child Neurology 1991;33:795-802.
14. Haidukewyech D, John G, Zielinski JJ. Chronic valproic acid therapy and incidence of increases in venous plasma ammonia. Therapeutic Drug Monitoring 1985;7:290.
15. Zaccara G, Paganini M, Campostrini R, Moroni F, Valenza T, Messori A, Bartelli M, Arnetoli G, Zappoli R. Effects of associated antiepileptic treatment on valproate induced hyperammonemia. Therapeutic Drug Monitoring 1985;7:185-190.
16. Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. Journal of Pediatrics 1982;101:782.
17. Warter JM, Marescaux C, Brandt C, Rumbacg L, Micheletti G, Chabrier G, Imler M, Kurtz D. Sodium valproate associated with phenobarbital: Effects on ammonemia metabolism in humans. Epilepsia 1983;24: 628-633.
18. Rath A, Naryanan TJ, Chowdhary GV, Murphy JM. Valproate-induced hyperammonemic encephalopathy with normal liver function. Neurology India 2005;53:226-228.
19. Parize P. A valproate-induced encephalopathy without hyperammonemia. Annales d'anesthésie et de réanimation 2007;26:1078-1088.
20. Segura-Bruna N, Rodriguez-Campello A, Puente V, Roquer J. Valproate-induced hyperammonemic encephalopathy. Acta Neurologica Scandinavica 2006;114:1-7.
21. Gerstner T, Buesing D, Longin E, Bendl C, Wenzel D, Scheid B, Goetze G, Macke A, Lippert G, Klostermann W, Mayer G, Augspach-Hofmann R, Fitzek S, Haensch CA, Reuland M, Koenig SA. Valproic acid induced encephalopathy- 19 new cases in Germany from 1994 to 2003-a side effect associated to valproate-therapy not only in young children. Seizure 2006;15:443-448.
22. Stewart JT. Treatment of valproate-induced hyperammonemia. Journal of the American Geriatrics Society 2005;53: 1980.
23. Haute Autorité de Santé [Internet]. 27 October 2007. Available online at: http://www.has-sante.fr/portail/upload/ docs/application/pdf/ct-4885-duphalac-.pdf, accessed 7 April 2009.
24. Mariposa M, Bourgeois JA. Valproic acid-induced hyperammonemia. Journal of Clinical Psychopharmacology 2004;25:521-526.
25. Verrotti A, Trotta D, Morgese G, Chiarelli F. Valproateinduced hyperammonemic encephalopathy. Metabolic Brain Disease 2002;17:367-373.
26. Wadzinski J, Franks R, Roane D, Bayard M. Valproateassociated hyperammonemic encephalopathy. The Journal of the American Board of Family Medicine 2007;20: 499-502.